BruceSGillisMD

Adult Clinical & Laboratory Immunology, Preventive Medicine, Occupational Medicine

Physician

Dr. Gillis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I developed what is currently the first and only university medical center developed, award-winning, objective, peer-reviewed and published and FDA-compliant blood test for diagnosing fibromyalgia, an immune system disorder that is the result of the effects of dysfunctional peripheral blood mononuclear cells and their inability to produce normal quantities of particular chemokines and cytokines. We will soon commence a clinical vaccine trial at the Massachusetts General Hospital to reverse the biology of fibromyalgia.

Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1975 - 1977
Harvard School of Public HealthResidency, Occupational and Environmental Medicine, 1973 - 1974
University of Illinois College of MedicineClass of 1974

PubMed

1 citations
Identification of unique genomic signatures in patients with fibromyalgia and chronic pain.
Gayatry Mohapatra, Fabien Dachet, Louis J Coleman, Bruce Gillis, Frederick G Behm
Scientific Reports. 2024-02-17
7 citations
Repeated Mouse Lung Exposures to Stachybotrys chartarum Shift Immune Response from Type 1 to Type 2
Jamie H. Rosenblum Lichtenstein, Ramon M. Molina, Thomas C. Donaghey, Yi-Hsiang Hsu, Joel A. Mathews
American Journal of Respiratory Cell and Molecular Biology. 2016-09-30
26 citations
Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis
Daniel J. Wallace, Igor M. Gavin, Oleksly Karpenko, Farnaz Barkhordar, Bruce S. Gillis
Rheumatology International. 2015-06-01

Pathway to Prevent / Improve the Treatment of Deadly COVID-19 Infections Revealed in EpicGenetics-Funded Study of Thousands of Fibromyalgia PatientsApril 21st, 2021
7 Fibromyalgia Experts Discuss the Covid-19 VaccineFebruary 22nd, 2021
University of Illinois College of Medicine and EpicGenetics Deploy Test to Determine Patients Most Likely to Avoid Potentially Fatal Cytokine Storms That May Trigger the Most Severe Cases of COVID-19June 11th, 2020
Join now to see all